The clinical, myopathological, and genetic analysis of 155 Chinese mitochondrial ophthalmoplegia patients with mitochondrial DNA single large deletions
- PMID: 38018320
- PMCID: PMC10767604
- DOI: 10.1002/mgg3.2328
The clinical, myopathological, and genetic analysis of 155 Chinese mitochondrial ophthalmoplegia patients with mitochondrial DNA single large deletions
Abstract
Background: Progressive external ophthalmoplegia (PEO) is a common subtype of mitochondrial encephalomyopathy.
Objective: The study aimed to investigate the relationship between mitochondrial DNA (mtDNA) abnormalities, muscle pathology, and clinical manifestations in Chinese patients with single large-scale mtDNA deletion presenting with PEO.
Methods: This is a retrospective single-center study. Patients with PEO who had a single large deletion in mitochondrial DNA were included in this study. The associations were analyzed between mtDNA deletion patterns, myopathological changes, and clinical characteristics.
Results: In total, 155 patients with mitochondrial PEO carrying single large-scale mtDNA mutations were enrolled, including 137 chronic progressive external ophthalmoplegia (CPEO) and 18 Kearns-Sayre syndrome (KSS) patients. The onset ages were 9.61 ± 4.12 in KSS and 20.15 ± 9.06 in CPEO. The mtDNA deletions ranged from 2225 bp to 9131 bp, with m.8470_13446del being the most common. The KSS group showed longer deletions than the CPEO group (p = 0.004). Additionally, a higher number of deleted genes encoding respiratory chain complex subunits (p = 0.001) and tRNA genes (p = 0.009) were also observed in the KSS group. A weak negative correlation between the mtDNA deletion size and ages of onset (p < 0.001, r = -0.369) was observed. The proportion of ragged red fibers, ragged blue fibers, and cytochrome c negative fibers did not correlate significantly with onset ages (p > 0.05). However, a higher percentage of abnormal muscle fibers corresponds to an increased prevalence of exercise intolerance, limb muscle weakness, dysphagia, and cerebellar ataxia.
Conclusion: We reported a large Chinese cohort consisting of mitochondrial PEO patients with single large-scale mtDNA deletions. Our results demonstrated that the length and locations of mtDNA deletions may influence onset ages and clinical phenotypes. The severity of muscle pathology could not only indicate diagnosis but also may be associated with clinical manifestations beyond the extraocular muscles.
Keywords: Kearns-Sayre syndrome; chronic progressive external ophthalmoplegia; mitochondrial DNA; single large-scale deletion.
© 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Conflict of interest statement
No competing financial interest exists.
Figures



Similar articles
-
[Progressive external ophthalmoplegia and the Kearns-Sayre syndrome: a clinical and molecular study of 6 cases].Med Clin (Barc). 1995 Jul 1;105(5):180-4. Med Clin (Barc). 1995. PMID: 7630231 Spanish.
-
[Mitochondrial DNA mutations in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Aug;20(4):273-8. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003. PMID: 12903032 Chinese.
-
Ophthalmoplegia in Mitochondrial Disease.Yonsei Med J. 2018 Dec;59(10):1190-1196. doi: 10.3349/ymj.2018.59.10.1190. Yonsei Med J. 2018. PMID: 30450853 Free PMC article.
-
Progressive external ophthalmoplegia.Handb Clin Neurol. 2023;194:9-21. doi: 10.1016/B978-0-12-821751-1.00018-X. Handb Clin Neurol. 2023. PMID: 36813323 Free PMC article. Review.
-
[Deletions of mitochondrial DNA in Kearns-Sayre syndrome].Nihon Rinsho. 1993 Sep;51(9):2386-90. Nihon Rinsho. 1993. PMID: 8411717 Review. Japanese.
Cited by
-
Mitochondrial Chronic Progressive External Ophthalmoplegia.Brain Sci. 2024 Jan 27;14(2):135. doi: 10.3390/brainsci14020135. Brain Sci. 2024. PMID: 38391710 Free PMC article. Review.
References
-
- Anteneová, N. , Kelifová, S. , Kolářová, H. , Vondráčková, A. , Tóthová, I. , Lišková, P. , Magner, M. , Zámečník, J. , Hansíková, H. , Zeman, J. , Tesařová, M. , & Honzík, T. (2020). The phenotypic Spectrum of 47 Czech patients with single, large‐scale mitochondrial DNA deletions. Brain Sciences, 10(11), 766. 10.3390/brainsci10110766 - DOI - PMC - PubMed
-
- Björkman, K. , Vissing, J. , Østergaard, E. , Bindoff, L. A. , de Coo, I. F. M. , Engvall, M. , Hikmat, O. , Isohanni, P. , Kollberg, G. , Lindberg, C. , Majamaa, K. , Naess, K. , Uusimaa, J. , Tulinius, M. , & Darin, N. (2023). Phenotypic spectrum and clinical course of single large‐scale mitochondrial DNA deletion disease in the paediatric population: A multicentre study. Journal of Medical Genetics, 60(1), 65–73. 10.1136/jmedgenet-2021-108006 - DOI - PMC - PubMed
-
- Bua, E. , Johnson, J. , Herbst, A. , Delong, B. , McKenzie, D. , Salamat, S. , & Aiken, J. M. (2006). Mitochondrial DNA‐deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. American Journal of Human Genetics, 79(3), 469–480. 10.1086/507132 - DOI - PMC - PubMed
-
- Chinault, A. C. , Shaw, C. A. , Brundage, E. K. , Tang, L. Y. , & Wong, L. J. (2009). Application of dual‐genome oligonucleotide array‐based comparative genomic hybridization to the molecular diagnosis of mitochondrial DNA deletion and depletion syndromes. Genetics in Medicine, 11(7), 518–526. 10.1097/GIM.0b013e3181abd83c - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources